When Serena Williams opened about her weight loss struggles, she not only joined a growing list of celebrities openly discussing GLP-1 medications but also pushed the issue of access and affordability into the spotlight.

“I just couldn’t get my weight to where I needed to be at a healthy place and believe me, I don’t take shortcuts. I do everything but shortcuts,” Williams told NBC’s “Today” show.

Williams, who said she has lost 31 pounds since consistently taking the medication this year, is using her platform to normalize use of the drugs and push back on the narrative that taking them is the “easy way out.”

According to the latest KFF Health Tracking Poll , one in eight U.S. adults (12%) report having taken a GLP-1 drug such as Ozempic, Wegovy, or Mounjaro. Use is higher among peop

See Full Page